We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Island Setting Receives Improved Clinical Laboratory Diagnostics

By LabMedica International staff writers
Posted on 13 Jul 2009
A testing system is helping to improve efficiency in a hospital laboratory on the Isle of Guernsey.

The new system benefits both staff and patients. More...
Previously, different platforms meant multiple blood draws--one serum tube for each of the analyzers, usually three to four per patient-to obtain results as quickly as possible. The new workflow makes the phlebotomist's work easier and means less discomfort for the patient.

Two cobas 6000 analyzers linked to modular preanalytics from Roche (Burgess Hill, UK) are helping the laboratory at Princess Elizabeth Hospital (St Martins, Guernsey BCD) increase efficiency and become more self-sufficient.

"Although [we are] a small isolated lab, we try to do as much as possible ourselves. We were dealing with an escalating number of tests and when the time came to upgrade four aging analyzers in our clinical chemistry department, consolidation seemed an obvious solution," explained Nigel Turner, section head of clinical chemistry at the hospital. With 183 different assays, Roche offers tests on an automated serum work area (SWA) platform, thus providing an ideal solution for the Guernsey laboratory.

As the lab runs a multidisciplinary on-call system, people from various fields including hematology or histology are also required to run the analyzers outside normal core hours. Now, it is just one blood tube, one analyzer.

Roche Diagnostics helps health professionals detect, monitor, and manage the patient's medical condition more effectively.


Related Links:
Roche
Princess Elizabeth Hospital



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.